Description

Cardiac biomarkers are of great importance in the timely, accurate diagnosis and management of acute coronary syndrome as well as the prognosis. Diagnosis in the golden period is of utmost importance to institute therapy at the earliest and possibly reverse the myocardial damage. Cardiac biomarkers are also a powerful tool for triaging. According to a report by StrategyHelix, the global cardiac biomarkers market is set to increase by US$ 7.1 billion during 2022-2028, growing at a CAGR of 9.3% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for cardiac biomarkers. The global cardiac biomarkers market is segmented on the basis of type, location of testing, application, and region. On the basis of type, the global cardiac biomarkers market has been segmented into albumin, creatine kinase-MB (CK-MB), low-density lipoproteins (LDL) and high-density lipoproteins (HDL), myoglobin, natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP), troponins, others. By location of testing, the global cardiac biomarkers market has been segmented into laboratory testing, point of care testing. Based on application, the global cardiac biomarkers market is categorized into acute coronary syndrome, atherosclerosis, congestive heart failure, myocardial infarction, others. Geographically, the global cardiac biomarkers market is segmented into North America, Asia Pacific, Europe, Rest of the World (ROW).

The global cardiac biomarkers market is highly competitive. The cardiac biomarkers market is dominated by key players, which are Abbott Laboratories, ACS Biomarker B.V., bioMerieux S.A., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, QuidelOrtho Corporation, Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tosoh Bioscience Inc.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the cardiac biomarkers market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Type: albumin, creatine kinase-MB (CK-MB), low-density lipoproteins (LDL) and high-density lipoproteins (HDL), myoglobin, natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP), troponins, others
Location of testing: laboratory testing, point of care testing
Application: acute coronary syndrome, atherosclerosis, congestive heart failure, myocardial infarction, others
Region: North America, Asia Pacific, Europe, Rest of the World (ROW)
Years considered: this report covers the period 2018 to 2028


Key Benefits for Stakeholders

– Get a comprehensive picture of the global cardiac biomarkers market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Cardiac biomarkers market overview
Part 3. Market breakdown by type
– Albumin
– Creatine kinase-MB (CK-MB)
– Low-density lipoproteins (LDL) and high-density lipoproteins (HDL)
– Myoglobin
– Natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP)
– Troponins
– Others
Part 4. Market breakdown by location of testing
– Laboratory testing
– Point of care testing
Part 5. Market breakdown by application
– Acute coronary syndrome
– Atherosclerosis
– Congestive heart failure
– Myocardial infarction
– Others
Part 6. Market breakdown by region
– North America
– Asia Pacific
– Europe
– Rest of the World (ROW)
Part 7. Key companies
– Abbott Laboratories
– ACS Biomarker B.V.
– bioMerieux S.A.
– Bio-Rad Laboratories, Inc.
– Danaher Corporation
– F. Hoffmann-La Roche AG
– Johnson & Johnson
– Novartis AG
– QuidelOrtho Corporation
– Randox Laboratories Ltd.
– Siemens AG
– Thermo Fisher Scientific Inc.
– Tosoh Bioscience, Inc.
About StrategyHelix
Disclaimer


USD 650

Product Type

Industry Statistics

Release Date

June 2022

Region

Global

Pages

13

REQUEST SAMPLE

Global Cardiac Biomarkers Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Cardiac Biomarkers Market 2022

Please fill out our form and we will get back to you.

login